Mechanistically, TMAO promotes T2D by increasing fasting insulin, HOMA-IR, and glucose intolerance, and inducing adipose tissue inflammation (Gao et al., 2014; Dambrova et al., 2016). This evidence concerns the gene INS and type 2 diabetes mellitus.